This article needs additional citations for verification . Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Guacetisal" – news · newspapers · books · scholar · JSTOR (November 2023) ( Learn how and when to remove this message ) |
| | |
| Clinical data | |
|---|---|
| Trade names | Broncaspin; Balsacetil; Guaiaspir; Prontomucil |
| Other names | Aspirin guaiacol ester; O-Methoxyphenyl salicylate acetate |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.054.221 |
| Chemical and physical data | |
| Formula | C16H14O5 |
| Molar mass | 286.283 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 72 to 74.5 °C (161.6 to 166.1 °F) |
| |
| |
Guacetisal is a drug that has been used to treat inflammatory respiratory diseases. [1] Chemically, it is an ester resulting from the combination of aspirin and guaiacol.[ citation needed ]
| pyrazolones / pyrazolidines | |
|---|---|
| salicylates | |
| acetic acid derivatives and related substances | |
| oxicams | |
| propionic acid derivatives (profens) |
|
| n-arylanthranilic acids (fenamates) | |
| COX-2 inhibitors (coxibs) | |
| other | |
| NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; # WHO-Essential Medicines; † withdrawn drugs; ‡ veterinary use. | |
| | This drug article relating to the respiratory system is a stub. You can help Wikipedia by adding missing information. |